HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaofang Wang Selected Research

Small Interfering RNA (siRNA)

3/2019The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
1/2018HIF-2α-ILK Is Involved in Mesenchymal Stromal Cell Angiogenesis in Multiple Myeloma Under Hypoxic Conditions.
7/2015Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl-2 apoptotic pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaofang Wang Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 01/2003
18Infections
01/2022 - 06/2010
14Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2022 - 11/2003
12Inflammation (Inflammations)
11/2021 - 10/2008
12Autosomal Dominant Polycystic Kidney (ADPKD)
10/2021 - 11/2003
11Cysts
10/2021 - 11/2003
8Breast Neoplasms (Breast Cancer)
11/2021 - 06/2017
7Pre-Eclampsia (Preeclampsia)
02/2022 - 10/2015
7Neoplasm Metastasis (Metastasis)
01/2022 - 01/2003
7COVID-19
11/2021 - 01/2020
6Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2018
6Hypertrophy
01/2021 - 01/2015
5Malaria
01/2022 - 03/2011
5Pneumonia (Pneumonitis)
11/2021 - 01/2017
5Multiple Myeloma
01/2021 - 01/2011
5Huntington Disease (Huntington's Disease)
01/2019 - 06/2008
4Body Weight (Weight, Body)
09/2021 - 11/2003
4Disease Progression
01/2021 - 01/2010
4Virus Diseases (Viral Diseases)
01/2020 - 01/2017
4Fibrosis (Cirrhosis)
01/2019 - 11/2003
4Prostatic Neoplasms (Prostate Cancer)
01/2019 - 01/2014
4Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
02/2009 - 03/2002
3Triple Negative Breast Neoplasms
02/2022 - 06/2017
3Myocardial Infarction
01/2022 - 12/2011
3Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2015
3Bronchiolitis
01/2022 - 01/2020
3Malnutrition (Nutritional Deficiencies)
09/2021 - 01/2017
3Coinfection
01/2021 - 11/2011
3Communicable Diseases (Infectious Diseases)
01/2021 - 01/2020
3Human Influenza (Influenza)
01/2021 - 01/2019
3Ovarian Neoplasms (Ovarian Cancer)
11/2020 - 09/2018
3Necrosis
11/2019 - 03/2015
3Pneumococcal Infections
01/2018 - 01/2017
3Cognitive Dysfunction
12/2017 - 06/2015
2Hepatitis
01/2022 - 01/2021
2Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 03/2013
2Heart Failure
01/2022 - 01/2022
2Acute Liver Failure (Fulminant Hepatic Failure)
11/2021 - 11/2019
2Leukemia
10/2021 - 12/2019
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021 - 10/2017
2Tuberous Sclerosis (Bourneville's Disease)
01/2021 - 01/2020
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 05/2018
2Weight Loss (Weight Reduction)
01/2021 - 08/2020
2Osteosarcoma (Osteogenic Sarcoma)
10/2020 - 02/2018
2Cytokine Release Syndrome
09/2020 - 01/2020
2Encephalitis (Encephalitis, Rasmussen)
08/2020 - 12/2015
2Liver Neoplasms (Liver Cancer)
08/2020 - 09/2019

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
09/2021 - 03/2002
14CytokinesIBA
01/2021 - 10/2008
10Long Noncoding RNAIBA
11/2021 - 06/2017
10Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2015
9Antiviral Agents (Antivirals)IBA
08/2020 - 01/2017
8EnzymesIBA
03/2019 - 01/2003
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2015
7Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
10/2021 - 04/2005
7CalciumIBA
10/2021 - 02/2009
7Therapeutic UsesIBA
05/2021 - 10/2008
7Biological ProductsIBA
01/2021 - 03/2011
6VaccinesIBA
11/2021 - 06/2010
6Messenger RNA (mRNA)IBA
11/2021 - 01/2010
6Vasopressins (Vasopressin)IBA
10/2021 - 01/2008
6Angiotensin IIIBA
01/2021 - 10/2015
5Phosphotransferases (Kinase)IBA
01/2022 - 01/2016
5RNA (Ribonucleic Acid)IBA
10/2021 - 04/2019
51,2,4-trioxaneIBA
01/2021 - 03/2011
5Pharmaceutical PreparationsIBA
01/2020 - 03/2011
4CateninsIBA
02/2022 - 08/2017
4MicroRNAs (MicroRNA)IBA
11/2021 - 01/2017
4pevonedistatIBA
03/2019 - 01/2014
3Immunoglobulin G (IgG)IBA
03/2022 - 06/2011
3DNA (Deoxyribonucleic Acid)IBA
02/2022 - 03/2017
3artemisinin (artemisinine)IBA
01/2022 - 11/2016
3Antimalarials (Antimalarial Agents)IBA
01/2022 - 11/2016
3Competitive Endogenous RNAIBA
11/2021 - 01/2019
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 03/2015
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 01/2019
3Interferon Type IIBA
01/2020 - 01/2017
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2020 - 01/2016
3TolvaptanFDA Link
01/2020 - 04/2005
3Ligases (Synthetase)IBA
03/2019 - 01/2014
3Small Interfering RNA (siRNA)IBA
03/2019 - 07/2015
3polyglutamineIBA
11/2017 - 08/2009
3AutoantibodiesIBA
01/2016 - 01/2013
2Blood Glucose (Blood Sugar)IBA
03/2022 - 01/2022
2CollagenIBA
01/2022 - 11/2018
2Hemoglobins (Hemoglobin)IBA
01/2022 - 05/2018
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2022 - 01/2020
2Oxygen (Dioxygen)IBA
12/2021 - 01/2019
2Neutralizing AntibodiesIBA
11/2021 - 06/2011
2N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA
10/2021 - 02/2009
2Calcium-Sensing ReceptorsIBA
10/2021 - 02/2009
2lixivaptanIBA
10/2021 - 01/2019
2Interleukin-4 (Interleukin 4)IBA
01/2021 - 10/2008
2Alanine Transaminase (SGPT)IBA
01/2021 - 03/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020 - 09/2015
2Interleukin-10 (Interleukin 10)IBA
10/2020 - 01/2015

Therapy/Procedure

25Therapeutics
01/2022 - 11/2004
8Radiotherapy
11/2021 - 06/2016
4Mastectomy (Mammectomy)
11/2021 - 10/2017